In most countries with a high burden of tuberculosis, domestic health budgets and traditional donor funds have been used to fund TB care and prevention. Going forward, a new approach to financing health and therefore TB care and prevention is needed. To keep our citizens healthy and productive, we must pivot to increases in domestic funding, and innovative, domestically anchored financing models that are resilient, equitable, efficient, and scalable.
The global health financing architecture is undergoing a profound transformation, marked by a steady decline in traditional donor assistance, and this change presents a significant challenge but also a strategic opportunity to show ownership, strengthen national health systems, and to contribute to changes into multilateral engagement.
In a world full of conflicts as well as competing political and economic crises, health must be prioritized and invested in, by countries themselves and through global solidarity across nations and across public and private entities. Within health, prioritizing the fight against TB is a good way of ensuring that we care about the health of the poor and those that are most disadvantaged.







